Otsuka Pays Up to $1.1B to Buy Jnana, Adds Drug Discovery Capabilities

With an upfront $800 million payment and $325 million in potential milestones, Otsuka Pharmaceutical is acquiring Jnana Therapeutics’ drug discovery platform and rare disease candidate, the companies announced Thursday.